tiprankstipranks
Advertisement
Advertisement

SE:SYNACT Stock Latest News

SynAct Pharma Clarifies Large Shareholder’s Erroneous Share Sale Order
Company AnnouncementsSynAct Pharma Clarifies Large Shareholder’s Erroneous Share Sale Order
21h ago
SynAct Pharma to Showcase Lead Inflammation Drug Ahead of Key Rheumatoid Arthritis Data
PremiumCompany Announcements
SynAct Pharma to Showcase Lead Inflammation Drug Ahead of Key Rheumatoid Arthritis Data
8d ago
SynAct Pharma convenes AGM and opts to retain earnings
PremiumCompany Announcements
SynAct Pharma convenes AGM and opts to retain earnings
20d ago
SynAct Pharma Finishes Phase 2b Dosing in Rheumatoid Arthritis Study
PremiumCompany Announcements
SynAct Pharma Finishes Phase 2b Dosing in Rheumatoid Arthritis Study
21d ago
SynAct Pharma Targets New Partnerships Ahead of Key Resomelagon Data
PremiumCompany Announcements
SynAct Pharma Targets New Partnerships Ahead of Key Resomelagon Data
22d ago
SynAct Pharma Updates Nomination Committee Ahead of 2026 AGM
PremiumCompany AnnouncementsSynAct Pharma Updates Nomination Committee Ahead of 2026 AGM
1M ago
SynAct Pharma Publishes 2025 Annual Report on Inflammatory Disease Pipeline
Premium
Company Announcements
SynAct Pharma Publishes 2025 Annual Report on Inflammatory Disease Pipeline
1M ago
SynAct Pharma Raises Share Capital Through Directed Issue
Premium
Company Announcements
SynAct Pharma Raises Share Capital Through Directed Issue
2M ago
SynAct Pharma Starts Phase 2 Dengue Trial of Resomelagon in Brazil
PremiumCompany Announcements
SynAct Pharma Starts Phase 2 Dengue Trial of Resomelagon in Brazil
2M ago
SynAct Pharma Targets RA Partnerships With BIO-Europe Spring 2026 Showcase
PremiumCompany Announcements
SynAct Pharma Targets RA Partnerships With BIO-Europe Spring 2026 Showcase
2M ago
SynAct Pharma Sets Capital Markets Day as It Enters Key Clinical Inflection Point
PremiumCompany Announcements
SynAct Pharma Sets Capital Markets Day as It Enters Key Clinical Inflection Point
3M ago
SynAct Pharma Raises SEK 51.9 Million in Directed Share Issue to Strengthen Runway and Deal Leverage
PremiumCompany Announcements
SynAct Pharma Raises SEK 51.9 Million in Directed Share Issue to Strengthen Runway and Deal Leverage
3M ago
SynAct Pharma Plans SEK 45 Million Directed Share Issue to Bolster Clinical Runway
PremiumCompany AnnouncementsSynAct Pharma Plans SEK 45 Million Directed Share Issue to Bolster Clinical Runway
3M ago
SynAct Pharma Names New CFO Ahead of Pivotal Phase 2b Data
Premium
Company Announcements
SynAct Pharma Names New CFO Ahead of Pivotal Phase 2b Data
3M ago
SynAct Pharma Publishes 2025 Annual Results and Highlights R&D Focus
Premium
Company Announcements
SynAct Pharma Publishes 2025 Annual Results and Highlights R&D Focus
3M ago
SynAct Pharma Advances SEK 5 Million Share Buyback, Reacquires 212,307 Shares
PremiumCompany Announcements
SynAct Pharma Advances SEK 5 Million Share Buyback, Reacquires 212,307 Shares
3M ago
SynAct Pharma Plans Capital Markets Day Ahead of Key Clinical Readouts
PremiumCompany Announcements
SynAct Pharma Plans Capital Markets Day Ahead of Key Clinical Readouts
4M ago
SynAct Pharma Hits Recruitment Milestone in Phase 2b Rheumatoid Arthritis Trial
PremiumCompany Announcements
SynAct Pharma Hits Recruitment Milestone in Phase 2b Rheumatoid Arthritis Trial
4M ago
SynAct Pharma Launches Phase 2 RESPIRE Trial of Resomelagon in Viral Respiratory Insufficiency
PremiumCompany Announcements
SynAct Pharma Launches Phase 2 RESPIRE Trial of Resomelagon in Viral Respiratory Insufficiency
4M ago
SynAct Pharma Names Long-Serving Finance Executive as Interim CFO
PremiumCompany AnnouncementsSynAct Pharma Names Long-Serving Finance Executive as Interim CFO
4M ago
SynAct Pharma Launches Share Buyback to Optimize Capital Structure
Premium
Company Announcements
SynAct Pharma Launches Share Buyback to Optimize Capital Structure
5M ago
SynAct Pharma Leadership Enters Lock-Up Ahead of Key Clinical Milestones
Premium
Company Announcements
SynAct Pharma Leadership Enters Lock-Up Ahead of Key Clinical Milestones
5M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >